JP2023533772A5 - - Google Patents
Info
- Publication number
- JP2023533772A5 JP2023533772A5 JP2023501632A JP2023501632A JP2023533772A5 JP 2023533772 A5 JP2023533772 A5 JP 2023533772A5 JP 2023501632 A JP2023501632 A JP 2023501632A JP 2023501632 A JP2023501632 A JP 2023501632A JP 2023533772 A5 JP2023533772 A5 JP 2023533772A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- cov
- sars
- fragment
- covid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2010425.3 | 2020-07-07 | ||
| GB2010425.3A GB2596820A (en) | 2020-07-07 | 2020-07-07 | Combination vaccine |
| PCT/IB2021/056102 WO2022009121A1 (en) | 2020-07-07 | 2021-07-07 | Sars-cov-2 and influenza combination vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023533772A JP2023533772A (ja) | 2023-08-04 |
| JP2023533772A5 true JP2023533772A5 (https=) | 2024-07-16 |
Family
ID=72050416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501632A Pending JP2023533772A (ja) | 2020-07-07 | 2021-07-07 | ＳＡＲＳ－ＣｏＶ－２及びインフルエンザ混合ワクチン |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20230256085A1 (https=) |
| EP (1) | EP4178612A1 (https=) |
| JP (1) | JP2023533772A (https=) |
| KR (1) | KR20230049084A (https=) |
| CN (1) | CN117957016A (https=) |
| AR (1) | AR122899A1 (https=) |
| AU (1) | AU2021303789A1 (https=) |
| BR (1) | BR112023000323A2 (https=) |
| CA (1) | CA3184878A1 (https=) |
| CO (1) | CO2023001072A2 (https=) |
| GB (1) | GB2596820A (https=) |
| IL (1) | IL299735A (https=) |
| MX (1) | MX2023000411A (https=) |
| TW (1) | TW202207979A (https=) |
| WO (1) | WO2022009121A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA46766A (fr) | 2016-11-11 | 2019-09-18 | Modernatx Inc | Vaccin antigrippal |
| WO2018170245A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Broad spectrum influenza virus vaccine |
| IL297419B2 (en) | 2020-04-22 | 2025-02-01 | BioNTech SE | Coronavirus vaccine |
| CN113980140B (zh) * | 2020-10-23 | 2024-06-25 | 江苏省疾病预防控制中心(江苏省公共卫生研究院) | 融合蛋白及其应用 |
| CN113293145B (zh) * | 2021-02-01 | 2022-08-26 | 上海青赛生物科技有限公司 | 一种麻疹病毒活载体新冠疫苗 |
| WO2022221440A1 (en) * | 2021-04-14 | 2022-10-20 | Modernatx, Inc. | Influenza-coronavirus combination vaccines |
| MX2023013081A (es) * | 2021-05-05 | 2024-01-15 | Novavax Inc | Composiciones de coronavirus e influenza y métodos para utilizarlas. |
| CN113462700B (zh) * | 2021-05-07 | 2023-06-09 | 杨光华 | SARS-CoV-2线性DNA疫苗 |
| CN114717251B (zh) * | 2021-08-24 | 2023-03-24 | 广州恩宝生物医药科技有限公司 | 一种用于预防SARS-CoV-2原始株和Beta株的腺病毒载体疫苗 |
| US20240398930A1 (en) * | 2021-09-24 | 2024-12-05 | Bharat Biotech International Limited | A vaccine for coronavirus and influenza virus, and method for preparation thereof |
| CN113755644B (zh) * | 2021-09-24 | 2024-05-03 | 中国科学院武汉病毒研究所 | 一种检测新型冠状病毒Alpha和Delta突变体试剂盒及应用 |
| US12186387B2 (en) | 2021-11-29 | 2025-01-07 | BioNTech SE | Coronavirus vaccine |
| CN114891817A (zh) * | 2022-04-15 | 2022-08-12 | 华南理工大学 | 一种多聚肽及其制备方法与应用 |
| WO2024002985A1 (en) | 2022-06-26 | 2024-01-04 | BioNTech SE | Coronavirus vaccine |
| WO2024174012A1 (pt) * | 2023-02-24 | 2024-08-29 | Instituto Butantan | Composição imunogênica, uso da mesma e processo de obtenção de uma composição imunogênica combinada contra covid-19 e influenza sazonal |
| CN115992101B (zh) * | 2023-03-22 | 2023-07-28 | 深圳市卫光生物制品股份有限公司 | 一种流感病毒裂解疫苗原液的制备方法 |
| CN116350769B (zh) * | 2023-03-31 | 2024-07-19 | 北京吉诺卫生物科技有限公司 | 一种新冠病毒和流感病毒的联合疫苗、其制备方法与应用 |
| CN116327910B (zh) * | 2023-03-31 | 2024-05-03 | 北京吉诺卫生物科技有限公司 | 一种新冠病毒、流感病毒和/或rsv的联合疫苗、其制备方法与应用 |
| EP4710936A1 (en) * | 2023-05-10 | 2026-03-18 | National University Corporation Hokkaido University | Combination vaccine for prevention of influenza and coronavirus infections |
| CN118141906B (zh) * | 2024-02-22 | 2025-08-22 | 安徽智飞龙科马生物制药有限公司 | 一种新冠流感联合疫苗及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4737462A (en) | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
| US4518584A (en) | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
| GB9419979D0 (en) * | 1994-10-04 | 1994-11-16 | Medeva Holdings Bv | Vaccine compositions |
| CN1775287A (zh) * | 2004-11-16 | 2006-05-24 | 北京科兴生物制品有限公司 | 一种sars流感二价联合疫苗及其制备工艺 |
| GB0822001D0 (en) * | 2008-12-02 | 2009-01-07 | Glaxosmithkline Biolog Sa | Vaccine |
| CA2826058C (en) * | 2011-02-04 | 2017-06-06 | Zoetis Llc | Compositions for canine respiratory disease complex |
| GB201108879D0 (en) | 2011-05-25 | 2011-07-06 | Isis Innovation | Vector |
| US20130236494A1 (en) * | 2012-03-06 | 2013-09-12 | Crucell Holland B.V. | Vaccination against influenza |
| CN107961371B (zh) * | 2017-04-19 | 2020-08-11 | 武汉博沃生物科技有限公司 | 季节流感-rsv联合疫苗及其制备方法和应用 |
| CN110974950B (zh) * | 2020-03-05 | 2020-08-07 | 广州恩宝生物医药科技有限公司 | 一种用于预防SARS-CoV-2感染的腺病毒载体疫苗 |
| CN111217917B (zh) * | 2020-02-26 | 2020-10-23 | 康希诺生物股份公司 | 一种新型冠状病毒SARS-CoV-2疫苗及其制备方法 |
| CN111218458B (zh) * | 2020-02-27 | 2020-11-20 | 珠海丽凡达生物技术有限公司 | 编码SARS-CoV-2病毒抗原的mRNA和疫苗及疫苗的制备方法 |
-
2020
- 2020-07-07 GB GB2010425.3A patent/GB2596820A/en not_active Withdrawn
-
2021
- 2021-07-07 TW TW110125037A patent/TW202207979A/zh unknown
- 2021-07-07 MX MX2023000411A patent/MX2023000411A/es unknown
- 2021-07-07 AR ARP210101904A patent/AR122899A1/es unknown
- 2021-07-07 JP JP2023501632A patent/JP2023533772A/ja active Pending
- 2021-07-07 US US18/015,025 patent/US20230256085A1/en active Pending
- 2021-07-07 CA CA3184878A patent/CA3184878A1/en active Pending
- 2021-07-07 EP EP21740222.1A patent/EP4178612A1/en active Pending
- 2021-07-07 BR BR112023000323A patent/BR112023000323A2/pt unknown
- 2021-07-07 CN CN202180054553.3A patent/CN117957016A/zh active Pending
- 2021-07-07 KR KR1020237003756A patent/KR20230049084A/ko active Pending
- 2021-07-07 AU AU2021303789A patent/AU2021303789A1/en active Pending
- 2021-07-07 WO PCT/IB2021/056102 patent/WO2022009121A1/en not_active Ceased
- 2021-07-07 IL IL299735A patent/IL299735A/en unknown
-
2023
- 2023-01-31 CO CONC2023/0001072A patent/CO2023001072A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023533772A5 (https=) | ||
| JP6957580B2 (ja) | 新規多価ナノ粒子に基づくワクチン | |
| Matić et al. | Current view on novel vaccine technologies to combat human infectious diseases | |
| Chroboczek et al. | Virus-like particles as vaccine. | |
| CN111315407B (zh) | 一种广谱抗流感疫苗免疫原及其应用 | |
| JP2021100944A5 (https=) | ||
| Herbert et al. | Recombinant adenovirus expressing the haemagglutinin of peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR | |
| Stachyra et al. | DNA vaccines against influenza. | |
| US20110091501A1 (en) | Recombinant Rhinovirus Vectors | |
| García-Sastre et al. | Novel vaccine strategies against emerging viruses | |
| Gao et al. | A perspective on SARS-CoV-2 virus-like particles vaccines | |
| CN111787982A (zh) | 乙型肝炎免疫方案和组合物 | |
| Quan et al. | Progress in the development of virus-like particle vaccines against respiratory viruses | |
| Pandey et al. | Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses | |
| KR20180132742A (ko) | 바이러스 질환을 위한 범용 백신 | |
| CN118787737A (zh) | 乙型肝炎免疫方案和组合物 | |
| Wang et al. | Coronavirus disease-19 vaccine development utilizing promising technology | |
| CN110548136A (zh) | 汉坦病毒长肽疫苗 | |
| Karkhanis et al. | Mucosal vaccine vectors: replication-competent versus replication-deficient poxviruses | |
| CN110382518B (zh) | 用于血清型a型口蹄疫病毒的嵌合疫苗 | |
| Srinivas | Recent developments in vaccines strategies against human viral pathogens | |
| JP4797149B2 (ja) | インフルエンザウイルスに対するベクターワクチン | |
| US20040096462A1 (en) | Noval vaccine formulation consisting of dna vaccine and inactivated virus | |
| Mooney et al. | Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses | |
| JP2005170945A (ja) | インフルエンザ血球凝集素多価ワクチンの製造方法 |